Pulsenmore has priced a private placement expected to raise approximately $7.5 million in gross proceeds from a single healthcare-focused institutional investor. The company will sell 1,562,500 ordinary shares, or pre-funded warrants in lieu thereof, along with ordinary warrants to purchase up to 1,562,500 ordinary shares, at a combined price of $4.80 per ordinary share and accompanying warrant. The ordinary warrants have an exercise price of $4.80 per share, are exercisable immediately, and expire five years from issuance. Pulsenmore intends to use the net proceeds for marketing and commercialization activities, working capital, and general corporate purposes, with closing anticipated on or about June 26, 2026.
Pulsenmore Ltd. Ordinary SharesCompany raises $7.5M via private placement, providing capital for marketing and working capital.